| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.009 |